Circassia focused on developing immunotherapies for the treatment of allergies.
Business Model:
Revenue: $32.4M
Employees: 201-500
Address: Northbrook House
City: Oxford
State: england
Zip: OX4 4GA
Country: GB
Circassia focused on developing immunotherapies for the treatment of allergies.
Contact Phone:
Contact Email:
Listed Exchange:
London Stock Exchange
IPO Date:
3/21/2014
Ticker Symbol:
CIR
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2011 | Series D | 2 | $98M |
Imperial Innovations Invesco Imperial Innovations Imperial Innovations Invesco Imperial Innovations |
1/2007 | Series A | $11.8M | 1/2008 | Series B | 4 | $21.9M |
Imperial Innovations Lansdowne Partners Invesco Goldman Sachs Goldman Sachs Invesco Imperial Innovations Lansdowne Partners Invesco Goldman Sachs Goldman Sachs Invesco |
12/2009 | Series C | 3 | $24.8M |
Invesco Imperial Innovations Lansdowne Partners Imperial Innovations Invesco Imperial Innovations Lansdowne Partners Imperial Innovations |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|